You are here: Industry Insights > Serum

News List

Serum waives AstraZeneca shot indemnity for refugee programme expresspharma
December 23, 2021
The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the vaccine-sharing programme COVAX...
Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO firstwordpharma
August 09, 2021
Serum Institute of India CEO Adar Poonawalla said he is hopeful that Covovax will be launched in October, depending on DCGI approvals, for adults and for children by the first quarter of 2022, as reported The Economic Times.
Serum IL-35 Levels Tied to Bone Loss With Rheumatoid Arthritis drugs
September 27, 2019
Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA) ...
Serum Biomarker Linked to Brain Atrophy in Multiple Sclerosis drugs
September 12, 2019
Serum neurofilament light chain (sNFL) levels are significantly associated with clinical and neuroimaging outcomes in multiple sclerosis (MS), according to a study published online in JAMA Neurology.
Serum Institute of India and Intravacc to develop Bioneedles financialexpress
June 01, 2018
(L-R) Bruno Bruins, Dutch Minister for Medical Care and Sports,Mark Rutte, Prime Minister of the Netherlands,Thijs Veerman, CEO, Intravacc,Dr Suresh Jadhav
Serum Institute of India partners with Massachusetts Medical School, USA expressbpd
November 02, 2017
Serum Institute of India unveils advanced Rotasiil vaccine, and Rabishield monoclonal antibody globally – developed in partnership with Massachusetts Medical School, USA
M&As this week: Serum Institute of India, Fresenius, NanoCarrier pharmaceutical-technology
April 28, 2017
US-based biopharmaceutical company Nanotherapeutics has been acquired by Serum Institute of India.